New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review

Saved in:
Bibliographic Details
Main Authors: Filippos Panteleimon Chatzipieris, Athanasios Kokkalis, Nikitas Georgiou, Errikos Petsas, Ektoras Vasileios Apostolou, Georgios C. Vougioukalakis, Thomas Mavromoustakos
Format: Article
Language:English
Published: American Chemical Society 2025-06-01
Series:ACS Omega
Online Access:https://doi.org/10.1021/acsomega.5c00134
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839645802470834176
author Filippos Panteleimon Chatzipieris
Athanasios Kokkalis
Nikitas Georgiou
Errikos Petsas
Ektoras Vasileios Apostolou
Georgios C. Vougioukalakis
Thomas Mavromoustakos
author_facet Filippos Panteleimon Chatzipieris
Athanasios Kokkalis
Nikitas Georgiou
Errikos Petsas
Ektoras Vasileios Apostolou
Georgios C. Vougioukalakis
Thomas Mavromoustakos
author_sort Filippos Panteleimon Chatzipieris
collection DOAJ
format Article
id doaj-art-36e4a53cd2034f3dba68f30363db6189
institution Matheson Library
issn 2470-1343
language English
publishDate 2025-06-01
publisher American Chemical Society
record_format Article
series ACS Omega
spelling doaj-art-36e4a53cd2034f3dba68f30363db61892025-07-01T08:07:27ZengAmerican Chemical SocietyACS Omega2470-13432025-06-011025262082623210.1021/acsomega.5c00134New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A ReviewFilippos Panteleimon ChatzipierisAthanasios KokkalisNikitas GeorgiouErrikos PetsasEktoras Vasileios ApostolouGeorgios C. VougioukalakisThomas Mavromoustakoshttps://doi.org/10.1021/acsomega.5c00134
spellingShingle Filippos Panteleimon Chatzipieris
Athanasios Kokkalis
Nikitas Georgiou
Errikos Petsas
Ektoras Vasileios Apostolou
Georgios C. Vougioukalakis
Thomas Mavromoustakos
New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
ACS Omega
title New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
title_full New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
title_fullStr New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
title_full_unstemmed New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
title_short New Prospects in the Inhibition of Monoamine Oxidase‑B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer’s Disease: A Review
title_sort new prospects in the inhibition of monoamine oxidase b mao b utilizing propargylamine derivatives for the treatment of alzheimer s disease a review
url https://doi.org/10.1021/acsomega.5c00134
work_keys_str_mv AT filippospanteleimonchatzipieris newprospectsintheinhibitionofmonoamineoxidasebmaobutilizingpropargylaminederivativesforthetreatmentofalzheimersdiseaseareview
AT athanasioskokkalis newprospectsintheinhibitionofmonoamineoxidasebmaobutilizingpropargylaminederivativesforthetreatmentofalzheimersdiseaseareview
AT nikitasgeorgiou newprospectsintheinhibitionofmonoamineoxidasebmaobutilizingpropargylaminederivativesforthetreatmentofalzheimersdiseaseareview
AT errikospetsas newprospectsintheinhibitionofmonoamineoxidasebmaobutilizingpropargylaminederivativesforthetreatmentofalzheimersdiseaseareview
AT ektorasvasileiosapostolou newprospectsintheinhibitionofmonoamineoxidasebmaobutilizingpropargylaminederivativesforthetreatmentofalzheimersdiseaseareview
AT georgioscvougioukalakis newprospectsintheinhibitionofmonoamineoxidasebmaobutilizingpropargylaminederivativesforthetreatmentofalzheimersdiseaseareview
AT thomasmavromoustakos newprospectsintheinhibitionofmonoamineoxidasebmaobutilizingpropargylaminederivativesforthetreatmentofalzheimersdiseaseareview